- Home
- APPF vs LEGN Comparison
APPF vs LEGN Comparison
Compare APPF & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APPF
- LEGN
- Stock Information
- Founded
- APPF 2006
- LEGN 2014
- Country
- APPF United States
- LEGN United States
- Employees
- APPF N/A
- LEGN N/A
- Industry
- APPF Computer Software: Prepackaged Software
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- APPF Technology
- LEGN Health Care
- Exchange
- APPF Nasdaq
- LEGN Nasdaq
- Market Cap
- APPF 8.1B
- LEGN 9.1B
- IPO Year
- APPF 2015
- LEGN 2020
- Fundamental
- Price
- APPF $217.05
- LEGN $45.57
- Analyst Decision
- APPF Buy
- LEGN Strong Buy
- Analyst Count
- APPF 6
- LEGN 13
- Target Price
- APPF $270.67
- LEGN $81.46
- AVG Volume (30 Days)
- APPF 309.0K
- LEGN 1.3M
- Earning Date
- APPF 10-24-2024
- LEGN 11-12-2024
- Dividend Yield
- APPF N/A
- LEGN N/A
- EPS Growth
- APPF N/A
- LEGN N/A
- EPS
- APPF 3.53
- LEGN N/A
- Revenue
- APPF $762,368,000.00
- LEGN $455,991,000.00
- Revenue This Year
- APPF $28.01
- LEGN $108.95
- Revenue Next Year
- APPF $19.32
- LEGN $81.26
- P/E Ratio
- APPF $61.28
- LEGN N/A
- Revenue Growth
- APPF 33.12
- LEGN 176.93
- 52 Week Low
- APPF $164.29
- LEGN $38.60
- 52 Week High
- APPF $274.56
- LEGN $70.13
- Technical
- Relative Strength Index (RSI)
- APPF 50.23
- LEGN 44.41
- Support Level
- APPF $209.37
- LEGN $44.56
- Resistance Level
- APPF $216.42
- LEGN $46.15
- Average True Range (ATR)
- APPF 7.65
- LEGN 2.05
- MACD
- APPF 1.30
- LEGN 0.19
- Stochastic Oscillator
- APPF 55.16
- LEGN 33.83
About APPF AppFolio Inc.
AppFolio Inc is a provider of cloud-based software solutions for real estate industry. Its property management software provides property managers with an end-to-end solution to their business needs. Its products include cloud-based property management software (Appfolio Property Manager). It also offers value-added services, such as screening, risk mitigation and electronic payment services. The business activity of the firm predominantly functions through the United States and it generates revenue in the form of subscription fees.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.